Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningLymphomaCombined Modality TherapyLymphoma, Non-HodgkinTreatment OutcomeLymphoma, Mantle-CellRemission InductionSalvage TherapyHodgkin DiseaseStem CellsLymphoma, B-CellDisease-Free SurvivalCyclophosphamideEtoposideLymphoma, Large B-Cell, DiffuseCytarabineRecurrenceLymphoma, FollicularMyeloablative AgonistsVincristineSurvival RateCarmustineBone Marrow TransplantationHematopoietic Stem Cell MobilizationGraft vs Host DiseaseThiotepaBone Marrow PurgingSurvival AnalysisHematologic NeoplasmsLymphoma, T-Cell, PeripheralDoxorubicinWhole-Body IrradiationRetrospective StudiesAntibodies, Monoclonal, Murine-DerivedLymphoma, T-CellPrognosisBoronic AcidsAmyloidosisPyrazinesHematopoietic Stem CellsDexamethasoneBusulfanGraft SurvivalFollow-Up StudiesAntineoplastic Agents, AlkylatingPrednisoneAntineoplastic AgentsAntigens, CD34AutograftsThalidomideLiver TransplantationIfosfamideTime FactorsInduction ChemotherapyMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisPodophyllotoxinNeoplasm, ResidualTransplantation ChimeraMaintenance ChemotherapyTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationEnteropathy-Associated T-Cell LymphomaCell TransplantationMitoxantroneLymphoma, AIDS-RelatedAntibodies, MonoclonalLymphoma, Large-Cell, AnaplasticKidney TransplantationNeoplasms, Second PrimaryEmbryonic Stem CellsMyelodysplastic SyndromesIdarubicinFatal OutcomeLeukemia, Plasma CellInfusions, SpinalProspective StudiesCisplatinCarboplatinNeoplasm Recurrence, LocalAdult Stem CellsBlood Component RemovalImmunosuppressive AgentsChemotherapy, AdjuvantHistocompatibility TestingBurkitt LymphomaDrug Administration ScheduleLeukemiaRadioimmunotherapyFeasibility Studies